Integrated Proteins loses MD with immediate effect
Karanj Doshi quits abruptly on 29 June, citing personal reasons. Nano-cap with ₹279 cr market cap, revenue down 73.5%, left without a successor.
— 2 earlier stories on Integrated Proteins Ltd. →What's new
- Karanj Doshi resigned as MD effective 29 June 2026, citing personal reasons.
- Company confirms no other material reasons; departure also ends his KMP role.
- No successor announced; board met in Jamnagar to approve resignation.
Why this matters
For a nano-cap trading at a P/E of 1,233 with revenue down 73.5% and net profit of nil in the latest quarter, losing the MD with zero notice is a governance red flag. The absence of a handover or succession plan raises questions about operational continuity and investor confidence.
What we're watching
- Whether the board names a replacement before the July 3 stock split meeting.
- Any further KMP departures or governance changes.
- Impact on the already-planned stock split consideration.
The full read
Integrated Proteins is now without a managing director. Karanj Doshi resigned effective immediately on 29 June 2026, citing personal reasons. For a nano-cap with a ₹279 crore market cap, trailing revenues down 73.5%, and a latest quarterly net profit of ₹0, the abrupt departure of its top executive is a material blow. The company says there are no other reasons, but the resignation letter was tendered and accepted the same day—no handover, no successor named. The board met in Jamnagar to approve the exit. This leaves a leadership vacuum at a time when the business is already shrinking and the next board meeting, on July 3, is supposed to consider a stock split. Nano-caps lean heavily on key personnel; this one now has a governance gap with no timeline to fill it. The next board update will be watched closely for any succession plan.
Questions answered
- Why did the MD resign with immediate effect?
- Mr. Karanj Doshi cited personal reasons and priorities in his resignation letter. The company says there are no other material reasons behind the departure.
- What is Integrated Proteins' current financial health?
- Revenue fell 73.5% over the trailing period. In the latest quarter (Mar 2026), sales were ₹6 cr and net profit was zero. Market cap is ₹279 cr.
- Is there a successor in place?
- No. The board accepted the resignation but did not announce a replacement or timeline for finding one.
- How does this affect the stock split planned for July 3?
- The resignation adds leadership uncertainty ahead of the board meeting to consider a stock split. The split's approval or timeline could be impacted by the vacancy.
- What are the regulatory implications of losing the MD?
- As a key managerial person, the vacancy must be filled within a reasonable time under the Companies Act. Non-compliance could attract regulatory scrutiny from SEBI or ROC.
Integrated Proteins Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on INTEGFD →- 29 Jun 2026 · 6:35 PM IST Integrated Proteins loses MD with immediate effect
- 6d ago Integrated Proteins board to consider stock split on July 3
- 41d ago Integrated Proteins revenue drops 54% in FY26